PTEN reduction and loss have also been reported in human cancers [5,6,13,58] and in canine melanoma [16], hemangiosarcoma [17], osteosarcoma [18], and in CMTs and FMTs [2,22]. This evidence concerns the gene PTEN and angiosarcoma.